Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 1/20 | 0.48 |
| ▸ | LMNA | P02545 | 3/20 | 0.43 |
| ▸ | PTPN1 | P18031 | 1/20 | 0.42 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.42 |
| ▸ | PRKCA | P17252 | 2/20 | 0.42 |
| ▸ | AKT1 | P31749 | 2/20 | 0.42 |
| ▸ | PTK2 | Q05397 | 2/20 | 0.42 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.41 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.41 |
| ▸ | HPGD | P15428 | 3/20 | 0.41 |
| ▸ | MAPT | P10636 | 2/20 | 0.41 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5199522 | 0.89 | LMNA (0.51) | TSHRLMNAKMT2APRKCAAKT1 | |
| SCHEMBL7078462 | 0.89 | LMNA (0.51) | TSHRLMNAKMT2APRKCAAKT1 | |
| SCHEMBL7075802 | 0.85 | KDM4E (0.47) | TSHRLMNAKDM4EALDH1A1HPGD | |
| SCHEMBL6690906 | 0.76 | P4HB (0.53) | TSHRLMNAKMT2APRKCAAKT1 | |
| SCHEMBL13576463 | 0.75 | CYP2D6 (0.58) | TSHRPTPN1 | |
| SCHEMBL2353098 | 0.75 | CYP2D6 (0.58) | TSHRPTPN1 | |
| SCHEMBL1582644 | 0.75 | CYP2D6 (0.58) | TSHRPTPN1 | |
| SCHEMBL12716359 | 0.75 | CYP2D6 (0.58) | TSHRPTPN1 | |
| SCHEMBL9887803 | 0.75 | CYP2D6 (0.58) | TSHRPTPN1 | |
| SCHEMBL3556856 | 0.75 | CYP2D6 (0.58) | TSHRPTPN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1252171-B1 | METHOD FOR PREPARING FUNCTIONALISED BETA-(1,3)-GLUCAN DERIVATIVES | GOEMAR LAB SA (FR) | 2007-08-15 | — | — | EP | disclosed |
| EP-1252171-A1 | METHOD FOR PREPARING FUNCTIONALISED BETA-(1,3)-GLUCAN DERIVATIVES | LABORATOIRES GOEMAR S.A. (FR) | 2002-10-30 | — | — | EP | disclosed |
| WO-2001057053-A1 | METHOD FOR PREPARING FUNCTIONALISED BETA-(1,3)-GLUCAN DERIVATIVES | LABORATOIRES GOEMAR (FR) | 2001-08-09 | — | — | WO | disclosed |